NGKIF yields 2.16% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, NGKIF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of NGKIF + PFE for your $10,000?
NGK Insulators, Ltd., together with its subsidiaries, manufactures and sells electric power related equipment in Japan, North America, Europe, and Asia. The company operates through Environment Business, Digital Society Business, and Energy & Industry Business segments. It offers energy storage systems, including NAS batteries; suspension, long rod, station post, hollow, and pin post insulators; HONEYCERAM, a component for exhaust gas purification; diesel particulate filters that eliminates particulates in the exhaust gas emitted from diesel automobiles; and NOx sensors, which measures nitrogen oxide concentration in motor vehicle exhaust gas. The company also provides metal-related products, such as beryllium copper products, copper-nickel-tin alloy products, molds, and related parts; and various electronic components, such as piezoelectric micro actuators, high frequency components, and mold-cast ceramics, as well as EnerCera, a chip-type ceramic rechargeable battery. In addition, it offers ceramics for semiconductor manufacturing equipment, including ceramic heaters, electrostatic chucks, and components; and industrial process products, such as heating systems, kiln furniture and refractories, ceramic membranes and separators, glass-lining products, high temperature dust collectors, ceramic and vacuum pumps, radioactive waste treatment equipment, and gas analyzers, as well as C1 home-use water Purifiers. The company was incorporated in 1919 and is headquartered in Nagoya, Japan.
Full NGKIF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.